Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Dig Dis Sci ; 55(11): 3086-94, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20186482

ABSTRACT

BACKGROUND: Despite the availability of effective surveillance for colorectal cancer with colonoscopy, relatively few at-risk individuals utilize this option. Colon cancer chemoprevention might be a more acceptable alternative. Some epidemiologic studies have suggested that statins may have chemopreventive effects without the risks of nonsteroidal anti-inflammatory drugs, but other epidemiologic studies have found no effect of statins. METHODS: We aimed to evaluate the efficacy of atorvastatin in inducing apoptosis in vitro, in preventing polyp formation in the min mouse, and in preventing tumor growth in nude mice. RESULTS: Atorvastatin rapidly induces apoptosis in the HCT116 colon cancer cell line in vitro, and this effect is reversible with mevalonate and geranylgeranyl pyrophosphate, but less so by farnesyl pyrophosphate. Atorvastatin chow was ineffective in reducing polyp formation in the min mouse model, with no significant effect on polyp number. Atorvastatin was effective in significantly slowing the growth of HCT116 colon cancer cell xenografts in nude mice (p = 0.008). Further, this reduction is due to increased levels of apoptosis. CONCLUSIONS: Atorvastatin can induce apoptosis in vitro, through mevalonate and prenylation pathways. Atorvastatin, while not effective in preventing polyp formation in the min mouse model, was very effective in slowing tumor growth in a nude mouse model. Consistent with in vitro findings, increased apoptosis accounted for decreased tumor growth. Statins may have benefit in cancer by slowing tumor growth, rather than preventing tumor initiation.


Subject(s)
Apoptosis/drug effects , Colonic Neoplasms/prevention & control , Colonic Polyps/prevention & control , Heptanoic Acids/pharmacology , Heptanoic Acids/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Pyrroles/pharmacology , Pyrroles/therapeutic use , Xenograft Model Antitumor Assays , Animals , Atorvastatin , DNA Fragmentation , Disease Models, Animal , Immunoblotting , In Situ Nick-End Labeling , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Nude , Tumor Cells, Cultured
2.
J Neurosci Res ; 86(3): 512-24, 2008 Feb 15.
Article in English | MEDLINE | ID: mdl-17918739

ABSTRACT

Embryonic stem (ES) cells can generate neural progenitors and neurons in vitro and incorporate into the adult central nervous system (CNS) following transplantation, suggesting their therapeutic potential for treating neurological disorders. However, our understanding of the conditions that direct ES-derived neural progenitor (ESNP) migration and differentiation within different regions of the adult CNS is incomplete. Rodents treated with the chemoconvulsant kainic acid (KA) experience seizures and display hippocampal sclerosis, as well as enhanced hippocampal neurogenesis, similar to pathological findings in patients with temporal lobe epilepsy (TLE). To examine the potential for ESNPs to incorporate into the adult hippocampus and differentiate into hippocampal neurons or glia following seizure-induced damage, we compared the fates of ESNPs after they were transplanted into the CA3 region or fimbria 1 week following KA-induced seizures. After 4-8 weeks, ESNPs grafted into the CA3 region had migrated to the dentate gyrus (DG), where a small subset adopted neural stem cell fates and continued to proliferate, based on bromodeoxyuridine uptake. Others differentiated into neuroblasts or dentate granule neurons. In contrast, most ESNPs transplanted into the fimbria migrated extensively along existing fiber tracts and differentiated into oligodendrocytes or astrocytes. Hippocampal grafts in mice not subjected to seizures displayed a marked tendency to form tumors, and this effect was more pronounced in the DG than in the fimbria. Taken together, these data suggest that seizures induce molecular changes in the CA3 region and DG that promote region-specific neural differentiation and suppress tumor formation.


Subject(s)
Embryonic Stem Cells , Hippocampus/surgery , Neurons , Seizures/surgery , Stem Cell Transplantation , Animals , Astrocytes/pathology , Biomarkers/metabolism , Cell Differentiation , Cell Movement , Cell Proliferation , Cells, Cultured , Cellular Senescence , Convulsants , Dentate Gyrus/pathology , Embryonic Stem Cells/metabolism , Excitatory Amino Acid Agonists , Fornix, Brain/pathology , Hippocampus/pathology , Hippocampus/physiopathology , Kainic Acid , Mice , Mice, SCID , Nerve Degeneration/etiology , Oligodendroglia/pathology , Sclerosis , Seizures/chemically induced , Seizures/complications , Seizures/pathology , Seizures/physiopathology
3.
PLoS One ; 5(12): e15856, 2010 Dec 31.
Article in English | MEDLINE | ID: mdl-21209827

ABSTRACT

Stem cell therapies for neurodegenerative disorders require accurate delivery of the transplanted cells to the sites of damage. Numerous studies have established that fluid injections to the hippocampus can induce lesions in the dentate gyrus (DG) that lead to cell death within the upper blade. Using a mouse model of temporal lobe epilepsy, we previously observed that embryonic stem cell-derived neural progenitors (ESNPs) survive and differentiate within the granule cell layer after stereotaxic delivery to the DG, replacing the endogenous cells of the upper blade. To investigate the mechanisms for ESNP migration and repair in the DG, we examined the role of the chemokine CXCL12 in mice subjected to kainic acid-induced seizures. We now show that ESNPs transplanted into the DG show extensive migration through the upper blade, along the septotemporal axis of the hippocampus. Seizures upregulate CXCL12 and infusion of the CXCR4 antagonist AMD3100 by osmotic minipump attenuated ESNP migration. We also demonstrate that seizures promote the differentiation of transplanted ESNPs toward neuronal rather than astrocyte fates. These findings suggest that ESNPs transplanted into the adult rodent hippocampus migrate in response to cytokine-mediated signals.


Subject(s)
Chemokine CXCL12/metabolism , Embryonic Stem Cells/cytology , Hippocampus/metabolism , Neurons/metabolism , Stem Cells/cytology , Animals , Cell Differentiation , Cell Movement , Cell Survival , Dentate Gyrus , Epilepsy, Temporal Lobe/metabolism , Fibroblasts/cytology , Male , Mice , Seizures/metabolism
4.
Cancer Res ; 69(20): 8208-15, 2009 Oct 15.
Article in English | MEDLINE | ID: mdl-19808966

ABSTRACT

Patients with chronic ulcerative colitis are at increased risk of developing colorectal cancer. Although current hypotheses suggest that sporadic colorectal cancer is due to inability to control cancer stem cells, the cancer stem cell hypothesis has not yet been validated in colitis-associated cancer. Furthermore, the identification of the colitis to cancer transition is challenging. We recently showed that epithelial cells with the increased expression of aldehyde dehydrogenase in sporadic colon cancer correlate closely with tumor-initiating ability. We sought to determine whether ALDH can be used as a marker to isolate tumor-initiating populations from patients with chronic ulcerative colitis. We used fluorescence-activated cell sorting to identify precursor colon cancer stem cells from colitis patients and report both their transition to cancerous stem cells in xenografting studies as well as their ability to generate spheres in vitro. Similar to sporadic colon cancer, these colitis-derived tumors were capable of propagation as sphere cultures. However, unlike the origins of sporadic colon cancer, the primary colitic tissues did not express any histologic evidence of dysplasia. To elucidate a potential mechanism for our findings, we compared the stroma of these different environments and determined that at least one paracrine factor is up-regulated in the inflammatory and malignant stroma compared with resting, normal stroma. These data link colitis and cancer identifying potential tumor-initiating cells from colitic patients, suggesting that sphere and/or xenograft formation will be useful to survey colitic patients at risk of developing cancer.


Subject(s)
Aldehyde Dehydrogenase/metabolism , Colitis/pathology , Colonic Neoplasms/etiology , Colonic Neoplasms/pathology , Neoplastic Stem Cells/enzymology , Adenocarcinoma/enzymology , Adenocarcinoma/etiology , Adenocarcinoma/pathology , Animals , Colitis/enzymology , Colon/enzymology , Colon/pathology , Colonic Neoplasms/enzymology , Cytokines/metabolism , Flow Cytometry , Fluorescent Antibody Technique , Humans , Immunoenzyme Techniques , Mice , Mice, Inbred NOD , Mice, SCID , Neoplastic Stem Cells/pathology , Precancerous Conditions/enzymology , Precancerous Conditions/etiology , Precancerous Conditions/pathology , Protein Array Analysis , Spheroids, Cellular/enzymology , Spheroids, Cellular/pathology , Stromal Cells/enzymology , Stromal Cells/pathology , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL